CONMED Corp — Director's Dealing 2012

Aug 20, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-08-16

Reporting Person: GOLDEN JO ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-16	Common Stock	M	500	$16.46	Acquired	10117	Direct
2012-08-16	Common Stock	F	304	$27.09	Disposed	9813	Direct
2012-08-16	Common Stock	S	1100	$27.0547	Disposed	8713	Direct
2012-08-20	Common Stock	S	100	$27.18	Disposed	8613	Direct
2012-08-20	Common Stock	S	100	$27.09	Disposed	8513	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-16	Sars (Stock Appreciation Rights)	$16.46	M	500	Disposed	2019-06-01	Common Stock (500)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.08. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed or a ConMed security holder.

F2: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARS shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.